Skip to main content

In the News

FDA Approvals, In the News
Rituximab Combination Now Approved in 3 Blood Cancers
Read More
In the News, FDA Approvals
“Smart Bomb” First-in-Class Drug Rova-T Promising Novel Therapy for Small-Cell Lung Cancer
Read More
In the News
NIH-Supported Research Outlines the Genetic Architecture of Type 2 Diabetes
Read More
In the News
CMS’s Andy Slavitt Considers Delaying MACRA Implementation
Read More
FDA Approvals, In the News
Nuplazid First Drug Approved for Hallucinations and Delusions Associated with Parkinson’s Disease
Read More
FDA Approvals, In the News
Zynbrita a New Treatment Available for Relapsing Multiple Sclerosis
Read More
FDA Approvals, In the News
FDA Approves First Blood Test to Detect Gene Mutation Associated with Non–Small-Cell Lung Cancer
Read More
FDA Approvals, In the News
FDA Approves New Diagnostic Imaging Agent to Detect Rare Neuroendocrine Tumors
Read More
In the News, Lung Cancer, Oncology
New Data Show Osimertinib Effective as First-Line Treatment of NSCLC with EGFR Mutation
Lilly Ostrovsky
Read More
FDA Approvals, In the News
Venclexta FDA Approved for Patients with CLL
Read More
Page 4 of 7
Results 31 - 40 of 63